Literature DB >> 31928112

Left Ventricular Mass and Incident Chronic Kidney Disease.

Rajiv Agarwal1, Rebecca J Song2, Ramachandran S Vasan3,4,2,5, Vanessa Xanthakis3,6,5.   

Abstract

Chronic kidney disease (CKD) is associated with incident cardiovascular morbidity and mortality. Whether subclinical cardiovascular disease and target organ damage is associated with incident CKD is unknown. We investigated the relations of echocardiographic left ventricular mass (LVM) with incident CKD. We evaluated 2258 Framingham Offspring cohort participants (mean age, 57 years; 56% women) who underwent echocardiography at a routine examination and had an estimated glomerular filtration rate ≥60 mL/min per 1.73 m2. We used Cox proportional hazards regression with discrete time intervals to relate sex-standardized LVM (independent variable) to the incidence of CKD, defined as estimated glomerular filtration rate <60 L/min per 1.73 m2, on follow-up. During a median follow-up of 14.6 years, 373 (16.5%) participants developed incident CKD. Higher LVM was associated with higher risk of CKD after adjusting for prevalent cardiovascular disease, body mass index, systolic blood pressure, total and HDL (high-density lipoprotein) cholesterol, antihypertensive medication, smoking, and diabetes mellitus (hazard ratio, 1.15 [95% CI, 1.03-1.29]; P=0.017) per 1-SD increase in LVM g/m2. Further adjustment for baseline estimated glomerular filtration rate (adjusted hazard ratio, 1.16 [95% CI, 1.04-1.31]; P=0.010) and baseline urine albumin/creatinine ratio (adjusted hazard ratio, 1.18 [95% CI, 1.04-1.33]; P=0.009) slightly attenuated the association. In our community-based sample, LVM was associated with incident CKD prospectively, which suggests that the relations between CKD and subclinical cardiovascular disease may be bidirectional. Further studies are needed to confirm our findings.

Entities:  

Keywords:  cardiovascular diseases; hypertrophy, left ventricular; longitudinal studies; renal insufficiency, chronic; smoking

Mesh:

Substances:

Year:  2020        PMID: 31928112      PMCID: PMC7370937          DOI: 10.1161/HYPERTENSIONAHA.119.14258

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  22 in total

Review 1.  Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis.

Authors:  Jonatan Barrera-Chimal; Sophie Girerd; Frederic Jaisser
Journal:  Kidney Int       Date:  2019-03-13       Impact factor: 10.612

2.  Blood pressure as a cardiovascular risk factor: prevention and treatment.

Authors:  W B Kannel
Journal:  JAMA       Date:  1996 May 22-29       Impact factor: 56.272

3.  Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.

Authors:  Chi-yuan Hsu; Charles E McCulloch; Jeanne Darbinian; Alan S Go; Carlos Iribarren
Journal:  Arch Intern Med       Date:  2005-04-25

4.  Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

Authors:  J Coresh; G L Wei; G McQuillan; F L Brancati; A S Levey; C Jones; M J Klag
Journal:  Arch Intern Med       Date:  2001-05-14

5.  Correlates of systolic hypertension in patients with chronic kidney disease.

Authors:  Rajiv Agarwal; Martin J Andersen
Journal:  Hypertension       Date:  2005-08-15       Impact factor: 10.190

6.  Blood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP).

Authors:  J Hunter Young; Michael J Klag; Paul Muntner; Joanna L Whyte; Marco Pahor; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

7.  The prognostic significance of proteinuria: the Framingham study.

Authors:  W B Kannel; M J Stampfer; W P Castelli; J Verter
Journal:  Am Heart J       Date:  1984-11       Impact factor: 4.749

Review 8.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

9.  Longitudinal Study of Left Ventricular Mass Growth: Comparative Study of Clinic and Ambulatory Systolic Blood Pressure in Chronic Kidney Disease.

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2016-02-01       Impact factor: 10.190

10.  Diffuse interstitial fibrosis and myocardial dysfunction in early chronic kidney disease.

Authors:  Nicola C Edwards; William E Moody; Mengshi Yuan; Manvir K Hayer; Charles J Ferro; Jonathan N Townend; Richard P Steeds
Journal:  Am J Cardiol       Date:  2015-02-12       Impact factor: 2.778

View more
  4 in total

Review 1.  Cardiovascular Disease Risk Reduction and Body Mass Index.

Authors:  Rohan Samson; Pierre Vladimir Ennezat; Thierry H Le Jemtel; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2022-07-05       Impact factor: 4.592

2.  Echocardiographic measures and subsequent decline in kidney function in older adults: the Atherosclerosis Risk in Communities Study.

Authors:  Junichi Ishigami; Lena Mathews; Manabu Hishida; Dalane W Kitzman; Josef Coresh; Scott D Solomon; Amil M Shah; Kunihiro Matsushita
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-01-24       Impact factor: 6.875

Review 3.  Risk for subsequent hypertension and cardiovascular disease after living kidney donation: is it clinically relevant?

Authors:  Charles J Ferro; Jonathan N Townend
Journal:  Clin Kidney J       Date:  2021-12-13

4.  Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications.

Authors:  Anna Birukov; Fabian Eichelmann; Olga Kuxhaus; Elli Polemiti; Andreas Fritsche; Janine Wirth; Heiner Boeing; Cornelia Weikert; Matthias B Schulze
Journal:  Diabetes Care       Date:  2020-08-17       Impact factor: 19.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.